Natera, Inc.

NASDAQ:NTRA

148.22 (USD) • At close March 14, 2025
Bedrijfsnaam Natera, Inc.
Symbool NTRA
Munteenheid USD
Prijs 148.22
Beurswaarde 20,037,268,920
Dividendpercentage 0%
52-weken bereik 83.13 - 183
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Steven Leonard Chapman
Website https://www.natera.com

An error occurred while fetching data.

Over Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene

Vergelijkbare Aandelen

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

98.94 USD

LivaNova PLC logo

LivaNova PLC

LIVN

39.24 USD

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

23.6 USD

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

ARWR

15.36 USD

CureVac N.V. logo

CureVac N.V.

CVAC

3.01 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

7.99 USD

Blueprint Medicines Corporation logo

Blueprint Medicines Corporation

BPMC

89.58 USD

Cytokinetics, Incorporated logo

Cytokinetics, Incorporated

CYTK

44.36 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)